Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery

Clinical Proteomics

Volumn 11, Issue 1, 2014, Pages

  Liu, Huan ^a,b   Zhang, Ningbo ^a,b   Wan, Debin ^a,b   Cui, Meng ^a   Liu, Zhiqiang ^a   Liu, Shuying ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Cancer biomarker; Glycoproteins; Mass spectrometry

Indexed keywords

GLYCAN; GLYCOPROTEIN; SIALOGLYCOPROTEIN; TUMOR MARKER;

BREAST CANCER; COLORECTAL CANCER; ELECTROSPRAY; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; MASS SPECTROMETER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE MYELOMA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PROCESSING; PROTEIN STRUCTURE; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; REVIEW; TANDEM MASS SPECTROMETRY;

EID: 84901979602     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-11-14     Document Type: Review

References (67)

1. An HJ, Froehlich JW, Lebrilla CB: Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Curr Opin Chem Bio 2009, 13(4):421-426.
2. Tian Y, Esteva FJ, Song J, Zhang H: Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry. Mol Cell Proteomics 2012, 11(6). DOI:10.1074/mcp.M111.011403.
3. Tian Y, Zhang H: Characterization of disease-Associated N-linked glycoproteins. Proteomics 2013, 13(3-4):504-511.
4. Wu J, Xie X, Nie S, Buckanovich RJ, Lubman DM: Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis. J Proteome Res 2013, 12(7):3342-3352.
5. Hubbard SC, Boyce M, McVaugh CT, Peehl DM, Bertozzi CR: Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells. Bioorg Med Chem Lett 2011, 21(17):4945-4950.
6. Alley WR Jr, Mann BF, Novotny MV: High-sensitivity analytical approaches for the structural characterization of glycoproteins. Chem Rev 2013, 113(4):2668-2732.
7. Zauner G, Kozak RP, Gardner RA, Fernandes DL, Deelder AM, Wuhrer M: Protein O-glycosylation analysis. Biol Chem 2012, 393(8):687-708.
8. Patrie SM, Roth MJ, Kohler JJ: Introduction to glycosylation and mass spectrometry. Methods Mol Biol (Clifton, NJ) 2013, 951:1-17.
9. Dodds ED: Gas-phase dissociation of glycosylated peptide ions. Mass Spectrom Rev 2012, 31(6):666-682.
10. Pabst M, Altmann F: Glycan analysis by modern instrumental methods. Proteomics 2011, 11(4):631-643.
11. North SJ, Hitchen PG, Haslam SM, Dell A: Mass spectrometry in the analysis of N-linked and O-linked glycans. Curr Opin Chem Bio 2009, 19(5):498-506.
12. Han L, Costello CE: Mass spectrometry of glycans. Biochem-Moscow 2013, 78(7):710-720.
13. Hanisch F-G: Top-down sequencing of O-glycoproteins by in-source decay matrix-Assisted laser desorption ionization mass spectrometry for glycosylation site analysis. Anal Chem 2011, 83(12):4829-4837.
14. Ye H, Boyne MT II, Buhse LF, Hill J: Direct approach for qualitative and quantitative characterization of glycoproteins using tandem mass tags and an LTQ Orbitrap XL electron transfer dissociation hybrid mass spectrometer. Anal Chem 2013, 85(3):1531-1539.
15. Isailovic D, Kurulugama RT, Plasencia MD, Stokes ST, Kyselova Z, Goldman R, Mechref Y, Novotny MV, Clemmer DE: Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. J Proteome Res 2008, 7(3):1109-1117.
16. Hua S, An HJ, Ozcan S, Ro GS, Soares S, DeVere-White R, Lebrilla CB: Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst 2011, 136(18):3663-3671.
17. Tsai H-Y, Boonyapranai K, Sriyam S, Yu C-J, Wu S-W, Khoo K-H, Phutrakul S, Chen S-T: Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer. Proteomics 2011, 11(11):2162-2170.
18. Fanayan S, Hincapie M, Hancock WS: Using lectins to harvest the plasma/serum glycoproteome. Electrophoresis 2012, 33(12):1746-1754.
19. Ongay S, Boichenko A, Govorukhina N, Bischoff R: Glycopeptide enrichment and separation for protein glycosylation analysis. J Sep Sci 2012, 35(18):2341-2372.
20. Lazar IM, Lee W, Lazar AC: Glycoproteomics on the rise: established methods, advanced techniques, sophisticated biological applications. Electrophoresis 2013, 34(1):113-125.
21. Nicolardi S, van der Burgt YEM, Dragan I, Hensbergen PJ, Deelder AM: Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera. J Proteome Res 2013, 12(5):2260-2268.
22. Schirm M, Schoenhofen IC, Logan SM, Waldron KC, Thibault P: Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins. Anal Chem 2005, 77(23):7774-7782. (Pubitemid 41746246)
23. de Leoz, MLA, An HJ, Kronewitter S, Kim J, Beecroft S, Vinall R, Miyamoto S, White RDV, Lam KS, Lebrilla C: Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines. Dis Markers 2008, 25(4-5):243-258.
24. Kronewitter SR, de Leoz MLA, Peacock KS, McBride KR, An HJ, Miyamoto S, Leiserowitz GS, Lebrilla CB: Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. J Proteome Res 2010, 9(10):4952-4959.
25. Wada Y, Dell A, Haslam SM, Tissot B, Canis K, Azadi P, Backstrom M, Costello CE, Hansson GC, Hiki Y, Ishihara M, Ito H, Kakehi K, Karlsson N, Hayes CE, Kato K, Kawasaki N, Khoo K-H, Kobayashi K, Kolarich D, Kondo A, Lebrilla C, Nakano M, Narimatsu H, Novak J, Novotny MV, Ohno E, Packer NH, Palaima E, Renfrow MB, et al: Comparison of methods for profiling O-Glycosylation human proteome organisation human disease glycomics/proteome initiative multi-institutional study OF IgA1. Mol Cell Proteomics 2010, 9(4):719-727.
26. Kyselova Z, Mechref Y, Kang P, Goetz JA, Dobrolecki LE, Sledge GW, Schnaper L, Hickey RJ, Malkas LH, Novotny MV: Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem 2008, 54(7):1166-1175. (Pubitemid 352009693)
27. Hu Y, Desantos-Garcia JL, Mechref Y: Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 2013, 27(8):865-877.
28. Dai L, Liu Y, He J, Flack CG, Talsma CE, Crowley JG, Muraszko KM, Fan X, Lubman DM: Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with gamma-secretase inhibitor. Proteomics 2011, 11(20):4021-4028.
29. Zhou L, Beuerman RW, Chew AP, Koh SK, Cafaro TA, Urrets-Zavalia EA, Urrets-Zavalia JA, Li SFY, Serra HM: Quantitative analysis of N-linked glycoproteins in tear fluid of climatic droplet keratopathy by glycopeptide capture and iTRAQ. J Proteome Res 2009, 8(4):1992-2003.
30. Zhou W, Hakansson K: Structural characterization of carbohydrates by fourier transform tandem mass spectrometry. Curr Proteomics 2011, 8(4):297-308.
31. de Leoz, MLA, Young LJT, An HJ, Kronewitter SR, Kim J, Miyamoto S, Borowsky AD, Chew HK, Lebrilla CB: High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics 2011, 10(1). DOI:10.1074/mcp. M110.002717.
32. Ahn YH, Kim KH, Shin PM, Ji ES, Kim H, Yoo JS: Identification of low-Abundance cancer biomarker candidate TIMP1 from serum with lectin fractionation and peptide affinity enrichment by ultrahigh-resolution mass spectrometry. Anal Chem 2012, 84(3):1425-1431.
33. Li QK, Shah P, Li Y, Aiyetan PO, Chen J, Yung R, Molena D, Gabrielson E, Askin F, Chan DW, Zhang H: Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-Associated glycoproteins from lung adenocarcinoma. J Proteome Res 2013, 12(8):3689-3696.
34. Gomes C, Almeida A, Ferreira JA, Silva L, Santos-Sousa H, Pinto-de-Sousa J, Santos LL, Amado F, Schwientek T, Levery SB, Mandel U, Causen H, David L, Reis CA, Osorio H: Glycoproteomic analysis of serum from patients with gastric precancerous lesions. J Proteome Res 2013, 12(3):1454-1466.
35. Alley WR Jr, Vasseur JA, Goetz JA, Syoboda M, Mann BF, Matei DE, Menning N, Hussein A, Mechref Y, Novotny MV: N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res 2012, 11(4):2282-2300.
36. Wu J, Xie X, Liu Y, He J, Benitez R, Buckanovich RJ, Lubman DM: Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS. J Proteome Res 2012, 11(9):4541-4552.
37. Zhu J, He J, Liu Y, Simeone DM, Lubman DM: Identification of glycoprotein markers for pancreatic cancer CD24(+)CD44(+) stem-like cells using nano-LC-MS/MS and tissue microarray. J Proteome Res 2012, 11(4):2272-2281.
38. Muinelo-Romay L, Villar-Portela S, Cuevas E, Gil-Martin E, Fernandez-Briera A: Identification of alpha(1, 6) fucosylated proteins differentially expressed in human colorectal cancer. Bmc Cancer 2011, 11. doi:10.1186/1471-2407-11-508.
39. Guthals A, Bandeira N: Peptide identification by tandem mass spectrometry with alternate fragmentation modes. Mol Cell Proteomics 2012, 11(9):550-557.
40. Domon B, Costello CE: A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconjugate J 1988, 5(4):397-409. (Pubitemid 19031141)
41. Nishikaze T, Kaneshiro K, Kawabata SI, Tanaka K: Structural analysis of N-Glycans by the glycan-labeling method using 3-Aminoquinoline-based liquid matrix in negative-Ion MALDI-MS. Anal Chem 2012, 84(21):9453-9461.
42. Ni W, Bones J, Karger BL: In-depth characterization of N-linked oligosaccharides using fluoride-mediated negative ion microfluidic chip LC-MS. Anal Chem 2013, 85(6):3127-3135.
43. Peterman SM, Mulholland JJ: A novel approach for identification and characterization of glycoproteins using a hybrid linear ion trap/FT-ICR mass spectrometer. J Am Soc Mass Spectrom 2006, 17(2):168-179. (Pubitemid 43185241)
44. Scott NE, Parker BL, Connolly AM, Paulech J, Edwards AVG, Crossett B, Falconer L, Kolarich D, Djordjevic SP, Hojrup P, Packer NH, Larsen MR, Cordwell SJ: Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation ms applied to the N-linked glycoproteome of campylobacter jejuni.Mol Cell Proteomics 2011, 10(2). DOI:10.1074/mcp.M000031-MCP201.
45. Singh C, Zampronio CG, Creese AJ, Cooper HJ: Higher energy collision dissociation (HCD) product ion-Triggered electron transfer dissociation (ETD) mass spectrometry for the analysis of N-linked glycoproteins. J Proteome Res 2012, 11(9):4517-4525.
46. Han L, Costello CE: Electron transfer dissociation of milk oligosaccharides. J Am Soc Mass Spectrom 2011, 22(6):997-1013.
47. Adamson JT, Hakansson K: Electron capture dissociation of oligosaccharides ionized with alkali, alkaline earth, and transition metals. Anal Chem 2007, 79(7):2901-2910. (Pubitemid 46595645)
48. Zhou W, Hakansson K: Electron detachment dissociation of fluorescently labeled sialylated oligosaccharides. Electrophoresis 2011, 32(24):3526-3535.
49. Seipert RR, Dodds ED, Clowers BH, Beecroft SM, German JB, Lebrilla CB: Factors that influence fragmentation behavior of N-linked glycopeptide ions. Anal Chem 2008, 80(10):3684-3692. (Pubitemid 351705868)
50. Kailemia MJ, Park M, Kaplan DA, Venot A, Boons GJ, Li L, Linhardt RJ, Amster IJ: High-field asymmetric-waveform ion mobility spectrometry and electron detachment dissociation of isobaric mixtures of glycosaminoglycans. J Am Soc Mass Spectrom 2014, 25(2):258-268.
51. Froehlich JW, Barboza M, Chu C, Lerno LA Jr, Clowers BH, Zivkovic AM, German JB, Lebrilla CB: Nano-LC-MS/MS of glycopeptides produced by nonspecific proteolysis enables rapid and extensive site-specific glycosylation determination. Anal Chem 2011, 83(14):5541-5547.
52. Ruhaak LR, Taylor SL, Miyamoto S, Kelly K, Leiserowitz GS, Gandara D, Lebrilla CB, Kim K: Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-Throughput analyses. Anal Bioanal Chem 2013, 405(14):4953-4958.
53. Ruhaak LR, Miyamoto S, Kelly K, Lebrilla CB: N-glycan profiling of dried blood spots. Anal Chem 2012, 84(1):396-402.
54. Goldman R, Ressom HW, Varghese RS, Goldman L, Bascug G, Loffredo CA, Abdel-Hamid M, Gouda I, Ezzat S, Kyselova Z, Mechref Y, Novotny MV: Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res 2009, 15(5):1808-1813.
55. Chen R, Tan Y, Wang M, Wang F, Yao Z, Dong L, Ye M, Wang H, Zou H: Development of glycoprotein capture-based label-free method for the high-Throughput screening of differential glycoproteins in hepatocellular carcinoma. Mol Cell Proteomics 2011, 10(7). DOI:10.1074/mcp.M110.006445.
56. Qin X, Chen Q, Sun C, Wang C, Peng Q, Xie L, Liu Y, Li S: High-Throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques. Med Oncol 2013, 30(1). DOI:10.1007/s12032-012-0420-8.
57. Tian Y, Yao Z, Roden RBS, Zhang H: Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics. Proteomics 2011, 11(24):4677-4687.
58. Zhang Y, Yin H, Lu H: Recent progress in quantitative glycoproteomics. Glycoconjugate J 2012, 29(5-6):249-258.
59. Orlando R: Quantitative analysis of glycoprotein glycans. Methods Mol Biol (Clifton, NJ) 2013, 951:197-215.
60. Kamiyama T, Yokoo H, Furukawa J-I, Kurogochi M, Togashi T, Miura N, Nakanishi K, Kamachi H, Kakisaka T, Tsuruga Y, Fujiyoshi M, Taketomi A, Nishimura S-I, Todo S: Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Hepatology 2013, 57(6):2314-2325.
61. Balog CIA, Stavenhagen K, Fung WLJ, Koeleman CA, McDonnell LA, Verhoeven A, Mesker WE, Tollenaar RAEM, Deelder AM, Wuhrer M: N-glycosylation of colorectal cancer tissues. Mol Cell Proteomics 2012, 11(9):571-585.
62. Gaye MM, Valentine SJ, Hu Y, Mirjankar N, Hammoud ZT, Mechref Y, Lavine BK, Clemmer DE: Ion mobility-mass spectrometry analysis of serum N-linked glycans from esophageal adenocarcinoma phenotypes. J Proteome Res 2012, 11(12):6102-6110.
63. Park S-Y, Lee S-H, Kawasaki N, Itoh S, Kang K, Ryu SH, Hashii N, Kim J-M, Kim J-Y, Kim JH: A1-3/4 fucosylation at Asn 241 of ss-haptoglobin is a novel marker for colon cancer: A combinatorial approach for development of glycan biomarkers. Int J Cancer 2012, 130(10):2366-2376.
64. Wang D, Hincapie M, Rejtar T, Karger BL: Ultrasensitive characterization of site-specific glycosylation of affinity-purified haptoglobin from lung cancer patient plasma using 10 mu m i.d. porous layer open tubular liquid chromatography-linear ion trap collision-induced dissociation/electron transfer dissociation mass spectrometry. Anal Chem 2011, 83(6):2029-2037.
65. Ahn YH, Shin PM, Kim Y-S, Oh NR, Ji ES, Kim KH, Lee YJ, Kim SH, Yoo JS: Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry. Analyst 2013, 138(21):6454-6462.
66. Chen G, Wang Y, Qin X, Li H, Guo Y, Wang Y, Liu H, Wang X, Song G, Li F, Li F, Guo S, Qiu L, Li Z: Change in IgG(1) Fc N-linked glycosylation in human lung cancer: Age-And sex-related diagnostic potential. Electrophoresis 2013, 34(16):2407-2416.
67. Chen G, Wang Y, Qiu L, Qin X, Liu H, Wang X, Wang Y, Song G, Li F, Guo Y, Li F, Guo S, Li Z: Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer. J Proteomics 2012, 75(10):2824-2834.